Skip to content
Friday, November 20, 2026
Responsive Menu
Home
Healthcare Newsdesk
The Latest UK Healthcare News brought to you by NTSI
Search
Search
Home
Care Home News
Carers
Medicine & Clinical Practice
Arthritis
Brain Conditions
Cancer
Colds and Flu
Diabetes
Diet & Exercise
Eyecare
Menopause
Mens Health
Mental Wellbeing
Psychology
Rare Medical Conditions
Smoking
Women’s Health
Physiotherapy
Private Practice
Recruitment
Wellbeing at Work
Home
Clinical News
Scoping review of interventions to de-implement potentially harmful non-steroidal anti-inflammatory drugs (NSAIDs) in healthcare settings
Clinical News
Scoping review of interventions to de-implement potentially harmful non-steroidal anti-inflammatory drugs (NSAIDs) in healthcare settings
April 17, 2024
Articles From The BMJ
Post navigation
De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease
Cost of SARS-CoV-2 self-test distribution programmes by different modalities: a micro-costing study in five countries (Brazil, Georgia, Malaysia, Ethiopia and the Philippines)